共 63 条
[1]
Abbasi M(2019)Strategies toward rheumatoid arthritis therapy; the old and the new J Cell Physiol 234 10018-10031
[2]
Van Den Bemt BJF(2009)Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs J Rheumatol 36 2164-2170
[3]
Vlieland ND(2016)The majority of patients do not store their biologic disease-modifying antirheumatic drugs within the recommended temperature range Rheumatol (United Kingdom) 55 704-709
[4]
Gardarsdottir H(2020)Global incidence and mortality trends due to adverse effects of medical treatment, 1990–2017: a systematic analysis from the global burden of diseases, injuries and risk factors study Cureus 14 34-40
[5]
Bouvy ML(2011)Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study Value Heal 24 1028-1033
[6]
Egberts TCG(2014)Direct health care costs of hospital admissions due to adverse events in the Netherlands Eur J Public Health 15 505-524
[7]
van den Bemt BJF(2019)Drug-related problems in patients with rheumatoid arthritis Ther Clin Risk Manag 38 942-948
[8]
Nauman J(2004)Comparison of drug-related problems in different patient groups Ann Pharmacother 84 2048-2058
[9]
Leendertse AJ(2018)Patient involvement is essential in identifying drug-related problems Br J Clin Pharmacol 37 674-680
[10]
Magdelijns FJH(2012)The contribution of patient interviews to the identification of drug-related problems in home medication review J Clin Pharm Ther 25 747-758